InvestorsHub Logo
Followers 19
Posts 817
Boards Moderated 0
Alias Born 12/12/2016

Re: A_Good_Day_2 post# 126800

Friday, 10/27/2017 1:18:02 PM

Friday, October 27, 2017 1:18:02 PM

Post# of 464000
AGD2 I’m largely expecting the valuation/fundamentals/disparity and investor frustration to continue until someone relents/acts: BP or FDA (bt/ft/aa designation/approvals) or bidding war.

We’ve clearly no control on the if/when.

UNLESS our CTAD late breaking presentation on 11/4 blows the doors off, we’ll continue to see no BP (including biib) offer any insight or public reference or tip of the cap or lend an ounce of credence towards Anavex, NOR will the entrenched tau/plaque scientific research establishment NOR those incentivized to continue the current Alzheimer’s treatments and facilities up and running.

Greed, pride and hubris will play huge roles (versus the patient 1st mentality).

Our potentially ground breaking MOA and (very promising) safe and effective test results to date (reference slides 25-30 from Oct presentation) likely are considered VERY DISRUPTIVE to those currently in control of the MULTI BILLION dollar treatment market.

Hence I’m fully expecting those with the power & influence in the CNS disease space (and/or those interested in keeping our valuation low for acquisition purposes) to cast shade, dismiss, negate, troll, and ensure zero press or mainstream analyst coverage towards Anavex.

Our CEO and BOD have their work cut out for them. GLTAL


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News